IPSEN (OTCMKTS:IPSEY) Shares Break Below Two Hundred Day Moving Average – Here’s What Happened

IPSEN (OTCMKTS:IPSEY – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $45.57 and traded as low as $45.12. IPSEN shares last traded at $45.12, with a volume of 2,564 shares traded.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on IPSEY. Jefferies Financial Group downgraded shares of IPSEN from a “hold” rating to a “moderate sell” rating in a research note on Sunday, August 2nd. Barclays raised IPSEN from a “strong sell” rating to a “hold” rating in a research note on Thursday, September 17th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold”.

Read Our Latest Stock Analysis on IPSEN

IPSEN Trading Down 0.0%

The business has a fifty day simple moving average of $43.15 and a two-hundred day simple moving average of $45.61.

About IPSEN

(Get Free Report)

IPSEN is a global biopharmaceutical company headquartered in France. Founded in 1929, it develops and commercializes medicines focused on oncology, rare diseases and neuroscience. Its portfolio includes treatments such as Somatuline for certain neuroendocrine tumors and acromegaly, Dysport for several neurological and aesthetic uses, and Cabometyx for certain cancers. The company also conducts research and development to advance medicines across its therapeutic areas. IPSEN serves patients and healthcare professionals in countries around the world through its international commercial operations and partnerships.

Further Reading

Receive News & Ratings for IPSEN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IPSEN and related companies with MarketBeat.com's FREE daily email newsletter.